Multimodal Ultrasound and Portal Hypertension
Learn more about:
Related Clinical Trial
Multimodal Ultrasound and Portal Hypertension
Portal Vein Access During Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedures
Acute Hemodynamic Response to Carvedilol in Children With Clinically Significant Portal Hypertension.
CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)
EUS-PPG vs HVPG in Portal Hypertension
Hepatic Venous Pressure Gradient and Elastography in Porto-sinusoidal Vascular Disorder
Portal Hypertension Using Magnetic Resonance Elastography
Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding
Portal Hypetension and Bariatric Surgery (BARIAPORTAL)
Non-invasive Diagnosis of Portal Hypertension in Cirrhosis Based on Metabolomics Technology
Evaluation of EUS in Preventing Rebleeding After Endoscopic Cyanoacrylate Injection for Gastric Varices
Relevance of Sarcopenia in Advanced Liver Disease
The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an Exploratory Pilot Study
Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomized Controlled Trial
3D-MRE for Assessing Cirrhosis and Portal Hypertension
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
Hepatectomy for Early-stage HCC Patients With CSPH
An AI Model Based on Smartphone-derived Multimodality Images to Evaluate Portal Hypertension in Patients With Cirrhosis (CHESS2203)
The Use of Endoscopic Ultrasound-Guided Portal Pressure Measurements to Guide Beta-Blocker Therapy in Patients With Compensated Cirrhosis
The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on Liver Reserve Function for Cirrhosis Patients
A Combined Model Based on Spleen Stiffness, Liver Stiffness and Platelets for Assessing Portal Hypertension in Compensated Cirrhosis.
Vonoprazan Efficacy to Prevent Post Variceal Band Ligation Ulcer
EUS vs TJ for Liver Biopsy and Portal Pressure Gradient Measurement
Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver Disease
A Novel Imging Based Quantitative Model-aided Detection of Portal Hypertension in Patients With Cirrhosis
A Novel Spleen-dedicated Stiffness Measured by FibroScan to Evaluate Cirrhotic Portal Hypertension (CHESS2105)
Myocardial Fibrosis and Inflammation in Liver Cirrhosis
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
Extension Study of Carvedilol RCT Study
Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal Hypertension
Characterization and Pathogenesis of ACLF
Timing of Endoscopy for Acute Variceal Bleeding in Patients With Cirrhosis
The Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in Cirrhosis
Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)
Efficacy and Safety of EUS-guided Coil Combined With Endoscopic Cyanoacrylate Injection Versus BRTO in Patients With Spontaneous Portosystemic Shunt
The Effect of Monitoring PVP on Clinical Outcomes in Patients With PH
Effect of Antiviral Therapy on HVPG in Patients With Viral Cirrhosis
Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension
Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal Hypertension
The vPPG-detecting Software Guided Management of Cirrhotic Portal Hypertension
Impact of Fentanyl Analgesia on the Accuracy of HVPG Measurements in Patients With Portal Hypertension
TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites
EUS Guided Portal-systemic Pressure Gradient Measurement
Endoscopic Ruler for the Assessment of Variceal Bleeding Risks (CHESS2005)
Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease
Liver Incytes for Portal Hypertension
Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14
Portal Pressure Effects of Phlebotomy Combined to Vasopressin Use in Cirrhotic Patients Undergoing Liver Transplantation
The Precise Selection of Stent Diameter for Portal Hypertension Patients With TIPS
A Physical Activity Program in End-state Liver Disease
MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI)
Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic Fibrosis
The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS
Ivabradine in Cirrhotic Cardiomyopathy
Telesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican Community
The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed
The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric Varices
TIPS With 8- OR 10-mm Covered Stent for Preventing Variceal Rebleeding
A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal Bleeding
Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis
MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis
Effects of a Novel Physical Exercise Program in Patients With Cirrhosis (the LFN-exercise Protocol)
Short Course Terlipressin for Control of Acute Variceal Bleeding
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis
Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis
Role of SWE-change After TIPS in the Prediction of Prognosis After TIPS
Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction
Injection of Cyanoacrylate+Lipiodol vs Cyanoacrylate+Lauromacrogol in Gastric Varices
Comparing Two Methods to Stop Vomiting of Blood Using the Endoscope
Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis
A Prospective Evaluation of Computerized Tomographic(CT) Scanning as a Screening Modality for Esophageal Varices
Secondary Prophylaxis After Variceal Bleeding in Non-Responders
VICIS – Vienna Cirrhosis Study
The Influence of Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy
Impact of Transjugular Intrahepatic Portosystemic Shunts on Liver Stiffness
Treatment for Prevention of Variceal Rebleeding Guided by the Hemodynamic Response
Quality of Life and Nutritional Improvements in Cirrhotic Patients
Effects of Dark vs. White Chocolate on the Postprandial Increase in Portal Pressure in Cirrhosis
8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding in Patients With Child A Cirrhosis
3D CT Guidance for Transjugular Intrahepatic Portosystemic Shunt Creation
8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding
Evaluation of 3D Overlay During Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure
RCT of Carvedilol Versus Variceal Band Ligation in the Primary Prophylaxis of Oesophageal Variceal Haemorrhage
Perioperative Care of HVPG Measurement (CHESS1904): An International Multicenter Survey
Surrogate Markers of Portal Pressure
A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis
DS-MCE vs EGD for Diagnosing Gastroesophageal Varices
Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis
Transfusion Requirements in Gastrointestinal (GI) Bleeding
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
Austrian Registry on Transjugular Intrahepatic Portosystemic Shunts
Somatostatin in Living Donor Liver Transplantation
The International Imaging Registry in Liver Cirrhosis (BAVENO-VI SPSS GROUP).
Non-invasive Method for Predicting the Presence of Gastroesophageal Varices in Patients With Cirrhosis
Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding
Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE
3D Sonographic Measurement of Volumetric Flow in Transjugular Intrahepatic Porto-Systemic Shunts
Endoscopic Variceal Ligation (EVL)+ Drugs Versus Endoscopic Variceal Ligation (EVL) Alone For Secondary Prophylaxis
Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive Assessment
The Role of Somatostatin in the Hemodynamics of the Hepatic Circulation in Patients Undergoing Liver Resection
TIPS in Fundal Variceal Bleeding (the TFB Study)
Prevention of Esophageal Varices by Beta-Adrenergic Blockers
Evaluation Of The Portal Pressure By Doppler Ultrasound In Cirrhotic Patients Before And After Simvastatin
Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis
Vasoactive Peptides in Portal Pressure
Correlation of Platelets Count With Endoscopic Findings in a Cohort of Egyptian Patients With Liver Cirrhosis
Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients
Non-invasive Evaluation Program for TIPS and Follow Up Network
A Novel Approach for Transjugular Intrahepatic Portocaval Shunt Creation Using Real-time Three Dimensional Roadmap
Carvedilol for Prevention of Esophageal Varices Progression
Feasibility And Safety Of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Using A Radiofrequency Guidewire
A Pilot Study: Defining Peripheral Endothelial Function in Portal Hypertensive Cirrhotic Patients
Anticoagulation Therapy After Splenectomy in Cirrhosis Patient
Esophageal Capsule Endoscopy in Children
Splenic Embolization for Portal Hypertension
Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis
HVPG for Rebleeding Risk Stratification
Non-invasive Evaluation Program for TIPS and Follow Up Network 2 (NEPTUN2)
Early TIPS for Ascites Study
Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPS
Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation
Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices
Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure
MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy
Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension
Can MRI Evaluate Beta-blocker Response in Portal Hypertension?
Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis
Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C)
Danish Carvedilol Study in Portal Hypertension
Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension
The Effect of Probiotics (VSL) on Portal Hypertension
Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients
HVPG-guided Laparoscopic Versus Endoscopic Therapy for Variceal Rebleeding in Portal Hypertension: A Multicenter Randomized Controlled Trial (CHESS1803)
Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension
Evaluation of Probiotics in the Treatment of Portal Hypertension
Simvastatin Effect on Portal Hypertension
Doppler Ultrasound Hepatic Vein Waveform as a Non-invasive Tool in the Assessment of Severity of Portal Hypertension
Value of Von Willebrand Factor in Portal Hypertension
A Study to Investigate the Safety and Effect of the Study Drug (FE 204205) in Patients With Cirrhotic Portal Hypertension
Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension
Viatorr CX Case-control Study for Complications of Portal Hypertension
Risk Factors for Variceal Bleeding in Egyptian Patients With Non-Cirrhotic Portal Hypertension
Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension
Assessment of Portal Hypertension With Multiparametric MRI
Portal Hypertension and Systemic Endothelial Function
Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled Trial
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension
Probiotics for Liver Cirrhosis With Portal Hypertension
WFA+M2BP in Evaluation of Portal Hypertension and Clinical Outcome in Patients With Liver Cirrhosis
Hemodynamic Effect of Simvastatin With Beta Blockers in Clinical Portal Hypertension
EGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients.
Treatment of Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir
Treatment of Moderate and Severe Cirrhotic Portal Hypertension Due to HBV With Fuzheng Huayu and Entecavir
Assessing Outcome After H-graft Shunt Placement
Microparticles in Cirrhosis and Portal Hypertension
ABMSC Infusion Through Hepatic Artery in Portal Hypertension Surgery for the Treatment of Liver Cirrhosis
MRI in Portal Hypertension
Study About Simvastatin in Portal Hypertension in Compensated Cirrhosis